Genome and pathogenicity analysis of Helicobacter mastomyrinus isolated from mice

Zhu Liqi1,2,3, Liang Yuanyuan1,2, Yang Linghan1,2

  • 1College of Veterinary Medicine, Institute of Comparative Medicine, Yangzhou University, Yangzhou, China.

Archives of Microbiology
|February 12, 2025
PubMed

Insights

Helicobacter mastomyrinus, a rodent bacterium, can cause liver and intestinal disease. Even isolates from healthy mice show significant pathogenic potential, including cytolethal distending toxin activity and hepatitis.

Area of Science:

  • Microbiology
  • Pathogenesis
  • Genomics

Background:

  • Enterohepatic Helicobacter species pose risks to humans and animals.
  • Helicobacter mastomyrinus (H. mastomyrinus) is linked to liver and intestinal issues, primarily in rodents.

Purpose of the Study:

  • To investigate the pathogenic potential of a H. mastomyrinus strain (Hm-17) isolated from asymptomatic mice.
  • To perform comprehensive analyses including genome sequencing, cytotoxicity, and animal pathogenicity.

Main Methods:

  • Genome sequencing and 16S rRNA analysis for phylogenetic relationships.
  • Core-pan genome analysis to assess pathogenic factor associations.
  • In vitro cytotoxicity assays for cytolethal distending toxin (CDT) activity.
  • In vivo pathogenicity testing in BALB/c mice.

Main Results:

  • Phylogenetic analysis showed H. mastomyrinus is closely related to H. canadensis, but core-pan genome analysis suggests a stronger link to H. hepaticus.
  • Hm-17 demonstrated significant cytolethal distending toxin (CDT) activity, causing cell swelling and death.
  • Infection with Hm-17 in mice led to rapid focal necrotic hepatitis.

Conclusions:

  • H. mastomyrinus isolates from asymptomatic hosts possess considerable pathogenic potential.
  • The organism's ability to induce CDT and hepatitis highlights its significance.
  • Further research is needed on H. mastomyrinus epidemiology and pathogenesis mechanisms.